Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-056770
Filing Date
2007-03-16
Accepted
2007-03-16 12:52:58
Documents
9
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 814749
2 SUBSIDIARY OF POINT THERAPEUTICS, INC. dex211.htm EX-21.1 1837
3 CONSENT OF ERNST & YOUNG LLP dex231.htm EX-23.1 1759
4 CERTIFICATION OF DONALD R. KIEPERT, JR. PURSUANT TO SECTION 302 dex311.htm EX-31.1 6726
5 CERTIFICATION OF RICHARD N. SMALL PURSUANT TO SECTION 302 dex312.htm EX-31.2 6681
6 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 5839
7 GRAPHIC g84880g10u18.jpg GRAPHIC 153119
8 GRAPHIC g84880g39k23.jpg GRAPHIC 157338
9 GRAPHIC g84880g87c12.jpg GRAPHIC 47051
  Complete submission text file 0001193125-07-056770.txt   1332147
Mailing Address 155 FEDERAL STREET BOSTON MA 02110
Business Address 155 FEDERAL STREET BOSTON MA 02110 6179332130
POINT THERAPEUTICS INC (Filer) CIK: 0000919745 (see all company filings)

EIN.: 043216862 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23776 | Film No.: 07698982
SIC: 2834 Pharmaceutical Preparations